CD47Fc (Trillium Therapeutics)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCD47Fc (Trillium Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionSignal-regulatory protein alpha stimulantsCluster of differentiation 47 modulators
TargetsCluster of differentiation 47Signal-regulatory protein alpha
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Health Network (Uhn)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrillium Therapeutics IncThe Hospital For Sick ChildrenUniversity Health Network (Uhn)
Active IndicationsN/A
Inactive IndicationsHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A
Related LinksN/A